The NASDAQ-listed Ocugen has rights to commercialise Covaxin in the US.

The United States will donate 750,000 COVID-19 vaccine doses to Taiwan as part of the country's plan to share shots globally, U.S. Senator Tammy Duckworth said on Sunday, offering a much-needed boost to the island's fight against the pandemic.

Taiwan is dealing with a spike in domestic cases but has been affected like many places by global vaccines shortages. Only around 3% of its 23.5 million people have been vaccinated, with most getting only the first shot of two needed.

Speaking at Taipei's downtown Songshan airport after arriving on a brief visit with fellow Senators Dan Sullivan and Christopher Coons, Duckworth said Taiwan would be getting 750,000 doses as part of the first tranche of U.S. donations.

"It was critical to the United States that Taiwan be included in the first group to receive vaccines because we recognise your urgent need and we value this partnership," she said at a news conference. She did not give details of which vaccines Taiwan would get or when.

Taiwan has complained about China, which claims the democratically-ruled island as its own, trying to block the island from accessing vaccines internationally, which Beijing has denied.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Taiwan to get 750,000 COVID-19 vaccine shots from US

Taiwan is dealing with a spike in domestic cases but has been affected like many places by global vaccines shortages. Only around 3% of its 23.5 million people have been vaccinated, with most getting only the first shot of two needed.

The NASDAQ-listed Ocugen has rights to commercialise Covaxin in the US.

Related stories